drugset / Trial / NCT00053378

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects

NCT00053378

Phase 2 Completed 45 enrolled Abbott
RandomizedFactorialDouble-blindTreatment

Summary

A study to determine the effect of Zemplar on the regulation of serum calcium levels and the need for administration of elemental calcium in hypocalcemic intensive care patients

Timeline

Start
2002-01
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Paricalcitol Other / unclassified

Indications

No indication recorded.